Sharmila Joshi of Peerless Securities recommends buying Aurobindo Pharma with a target of Rs 220 and advises selling GMR Infrastructure with a target of Rs 21.15.
first published: Oct 1, 2013 01:07 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

